Overview

The Evaluation of Bepreve on the Measurement of Wheal and Flare Response From Histamine Skin Prick Testing

Status:
Completed
Trial end date:
2010-06-01
Target enrollment:
Participant gender:
Summary
To evaluate the effect of BEPREVE compared to a REFRESH Tears Lubricant eye drop on the measurement of the wheal and flare from histamine skin prick testing. This is an open label, two-week, post-marketing study conducted on histamine responsive patients.
Phase:
Phase 4
Details
Lead Sponsor:
North Texas Institute for Clinical Trials
Treatments:
Bepotastine besilate
Histamine
Histamine phosphate